Evidence map›Paper›PMID 26585388›Full record

ArticleMolecular cell2015

A 3' Poly(A) Tract Is Required for LINE-1 Retrotransposition.

Aurélien J Doucet, Jeremy E Wilusz, Tomoichiro Miyoshi, Ying Liu, John V Moran

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 102 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
102citing papers in PubMed, 1 pooled it
25.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

102 citing papers in PubMed, 1 synthesis or guideline pooled it, 166 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

42 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Aurélien J DoucetDepartment of Human Genetics, University of Michigan Medical School, Ann Arbor, MI 48109-5618, USA. Electronic address: adoucet@umich.edu.
Jeremy E WiluszDepartment of Biochemistry and Biophysics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
Tomoichiro MiyoshiDepartment of Human Genetics, University of Michigan Medical School, Ann Arbor, MI 48109-5618, USA.
Ying LiuHoward Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, MI 48109-5618, USA.
John V MoranDepartment of Human Genetics, University of Michigan Medical School, Ann Arbor, MI 48109-5618, USA; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109-5618, USA; Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, MI 48109-5618, USA. Electronic address: moranj@umich.edu.
University of Michigan–Ann Arbor · USUniversity of Pennsylvania · US

Funding

REGULATION OF MRNA PROCESSINGR01GM034277 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI SHARP, PHILLIP A · 1985 to 2021
$8.0M
Gen. &Mol. Analysis of Human LINE-1 RetrotranspositionR01GM060518 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MORAN, JOHN V. · 1999 to 2024
$4.8M
Stress and Proliferation States Impact MicroRNA-Mediated Regulation in CancerR01CA133404 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI SHARP, PHILLIP A · 2008 to 2017
$4.6M
Regulation of noncoding RNA biogenesis and functionR00GM104166 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI WILUSZ, JEREMY E · 2014 to 2016
$735k
Howard Hughes Medical InstituteNCI NIH HHS R01 CA133404NCI NIH HHS R01-CA133404NIGMS NIH HHS GM060518NIGMS NIH HHS R00 GM104166NIGMS NIH HHS R00-GM104166NIGMS NIH HHS R01 GM034277NIGMS NIH HHS R01 GM060518NIGMS NIH HHS R01-GM34277
6 · The paper itself

Abstract

L1 retrotransposons express proteins (ORF1p and ORF2p) that preferentially mobilize their encoding RNA in cis, but they also can mobilize Alu RNA and, more rarely, cellular mRNAs in trans. Although these RNAs differ in sequence, each ends in a 3' polyadenosine (poly(A)) tract. Here, we replace the L1 polyadenylation signal with sequences derived from a non-polyadenylated long non-coding RNA (MALAT1), which can form a stabilizing triple helix at the 3' end of an RNA. L1/MALAT RNAs accumulate in cells, lack poly(A) tails, and are translated; however, they cannot retrotranspose in cis. Remarkably, the addition of a 16 or 40 base poly(A) tract downstream of the L1/MALAT triple helix restores retrotransposition in cis. The presence of a poly(A) tract also allows ORF2p to bind and mobilize RNAs in trans. Thus, a 3' poly(A) tract is critical for the retrotransposition of sequences that comprise approximately one billion base pairs of human DNA.

Indexed as

Long Interspersed Nucleotide ElementsEndonucleasesHeLa CellsHumansPoly ARNA-Directed DNA PolymeraseRNA, Long NoncodingRNA, MessengerEndonucleasesMALAT1 long non-coding RNA, humanORF2 protein, humanPoly ARNA-Directed DNA PolymeraseRNA, Long NoncodingRNA, Messenger

Identifiers

PMID26585388
PMCPMC4671821
OpenAlexW2210213181

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.